Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4297990

TEBENTAFUSP
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available
ChEMBL ↗

Basic Information

ChEMBL ID CHEMBL4297990
Name TEBENTAFUSP
Phase Approved
Structure Type SEQ
Therapeutic ✓ Yes

Known Names

IMCgp 100 IMCGP-100 Imcgp100 IMMTAC IMCGP100 ImmTAC IMCgpgp 100 Kimmtrak Tebentafusp Tebentafusp tebn Tebentafusp-tebn
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
9
Known Names
4
Indications
1
Mechanisms

Drug Information

Molecule Type Protein
First Approval 2022
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral

Flags

Black Box Warning First in Class
USAN Stem -fusp
USAN Year 2019

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Melanocyte protein PMEL binding agent BINDING AGENT Melanocyte protein PMEL ✓ ✓

Indications

Melanoma Neoplasms Uveal Neoplasms Uveal Melanoma

ATC Classification

L01XX75
tebentafusp
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS

Drug Warnings

Black Box Warning
General Warning
Country: United States

Data from ChEMBL 36 via Core Engine